相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons
Kathleen J. Griffioen et al.
CARDIOVASCULAR RESEARCH (2011)
A Pilot Study to Assess Whether Glucagon-Like Peptide-1 Protects the Heart From Ischemic Dysfunction and Attenuates Stunning After Coronary Balloon Occlusion in Humans
Philip A. Read et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies A retrospective analysis of the LifeLink database
Jennie H. Best et al.
DIABETES CARE (2011)
Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Murine Model of Dilated Cardiomyopathy
Arpita Kalla Vyas et al.
PLOS ONE (2011)
Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1
Renato O. Crajoinas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure
Que Liu et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study
Anne Gill et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
O. Erdogdu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Mechanical properties of primary cilia regulate the response to fluid flow
Susanna Rydholm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
The Adrenergic-Fatty Acid Load in Heart Failure
Lionel H. Opie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo
David Nathanson et al.
REGULATORY PEPTIDES (2009)
Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats
S. M. Gardiner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Diastolic stiffness of the failing diabetic heart - Importance of fibrosis, advanced glycation end products, and myocyte resting tension
Loek van Heerebeek et al.
CIRCULATION (2008)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity
Cendrine Cabou et al.
DIABETES (2008)
The potential beneficial role of glucagon-like peptide-1 in endothelial dysfunction and heart failure associated with insulin resistance
T. Nystroem
HORMONE AND METABOLIC RESEARCH (2008)
Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus
Prajakti A. Kothare et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart
David P. Sonne et al.
REGULATORY PEPTIDES (2008)
Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting
George G. Sokos et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
George G. Sokos et al.
JOURNAL OF CARDIAC FAILURE (2006)
Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats
SM Gardiner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
LA Nikolaidis et al.
CIRCULATION (2004)
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
LA Nikolaidis et al.
CIRCULATION (2004)
Gq/G13 signaling by ET-1 in smooth muscle:: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB
E Hersch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men
JP Gutzwiller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Cardiac function in mice lacking the glucagon-like peptide-1 receptor
R Gros et al.
ENDOCRINOLOGY (2003)
Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes
MGV Petroff et al.
CIRCULATION RESEARCH (2001)
分享论文
